Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
about
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrierSex steroids do not affect shigatoxin cytotoxicity on human renal tubular or glomerular cellsShiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applicationsp38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cellsEssential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.Detection of apoptosis in kidney biopsies of patients with D+ hemolytic uremic syndrome.New aspects in the pathogenesis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.Hemolytic uremic syndrome: pathogenesis and update of interventions.Shiga toxin pathogenesis: kidney complications and renal failure.A novel murine infection model for Shiga toxin-producing Escherichia coli.Multifaceted hemolytic uremic syndrome in pediatrics.Association of haemolytic uraemic syndrome with dysregulation of chemokine receptor expression in circulating monocytes.Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.Advances in haemolytic uraemic syndrome.Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome.Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharidesShiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory responseEffects of maternal serum on permeability of glomerular endothelial cell membrane.Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage.A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversityThe heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cellsVerotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.Microalbuminuria: causes and implications.Adenoviral E4 gene stimulates secretion of pigmental epithelium derived factor (PEDF) that maintains long-term survival of human glomerulus-derived endothelial cellsCardiovascular disease after Escherichia coli O157:H7 gastroenteritisShiga Toxin Mediated Neurologic Changes in Murine Model of Disease.Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.Shiga toxin and its use in targeted cancer therapy and imagingEndothelium--role in regulation of coagulation and inflammation.Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cellsShiga toxin 1 causes direct renal injury in rats.Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin
P2860
Q24644639-A391CA19-13FB-4F0A-837B-A1CABD23C5ACQ24803488-64666158-544A-4E27-8928-B0978F68B5FDQ26752966-0A53A73D-FC96-4935-AEB0-8A0E0AE9408AQ30441434-27BBB403-6404-4D5F-A05C-113274A586B5Q30453237-A36AFB12-8E76-48A4-AC09-3623831E5095Q33336219-7E88F8BD-CE46-436F-8AFF-9622DDF3EA9FQ33339749-5D685229-0B5E-445B-A0C4-74C00EB2F71BQ33379683-5BE1D24F-AA25-4193-917C-1B0DBAF48DA3Q33385809-59B8605D-2617-42EA-921B-2C0B28FE22B1Q33397541-7DB4093F-5FF9-46ED-9860-27064B37F091Q33403695-04544541-7369-4B42-8882-CD628CE6490FQ33405452-0AEA189D-0CEF-4D5B-8A83-7D4C6923B281Q33420958-8C52EA94-BF18-4A57-997E-35BCBAA634DEQ33427669-9B06ADCB-2129-42A6-98B3-1CB81D780711Q33501527-F6E96295-974A-40AC-B1EE-BEF0006D991AQ33502399-96977687-7EA4-4A6B-BFE7-F44D97AA4734Q33502724-C5A05CF2-6D66-4100-B83F-8B9B892B17BAQ33504952-0855AE15-A080-4407-962D-331C822017F4Q33557728-A284C77E-F47D-4816-A553-85B283B8BD96Q33675845-3C688498-DAA9-440E-986D-8B04DC54E5C5Q33808280-2F72EC71-CF51-4C37-B650-5C89E20CE558Q33825219-9D5812BC-D622-4F68-8992-EBE1D60C63BEQ33952458-109B4989-602D-4B5D-8EF1-43183D2B8718Q34000714-47E69F8C-453C-4C7B-8071-99DE33E7EA72Q34119320-F64F44A9-8B33-4EDF-B1DC-1AA53ABEA73DQ34143819-81AEC59D-C1C3-4D0C-AB54-0B0354DA57A6Q34412830-0FA8E9F3-644F-48FE-994C-4CFBACB30A40Q34922868-9ACF729D-2356-4839-82EE-B3EED2DDBD70Q35045942-58C3BABD-AB23-485C-A02B-C3B3C1B455E5Q35226330-0E737FBD-648A-49F5-B71E-39916800C7EAQ36386908-3E9BEB0C-3324-4D6F-80A2-8EA9215DB6E6Q36510758-947D0494-16B9-4A53-A9F0-1DFB09BA79AFQ37293251-28B9E9FC-296D-4970-8D62-CA6E8F1732EDQ37322141-949BADF2-2297-4509-B731-9C730552315DQ37831422-3E99F2DF-7235-41D9-9A8B-AE683D3489C6Q37918456-2C710828-0C41-43CD-864D-85EABE7458A0Q38024274-6D5DF300-3A0D-4E89-A72A-C49BABDF711FQ39376598-3583990E-5B6D-453B-A2EA-CA9E240B036CQ39392213-C3414793-31E0-4D63-B92B-8018451AB656Q39519000-23D3FF35-9474-4E0F-A7F0-FAAE7BA405C1
P2860
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@ast
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@en
type
label
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@ast
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@en
prefLabel
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@ast
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@en
P2093
P921
P356
P1433
P1476
Effects of TNF alpha on verocy ...... crovascular endothelial cells.
@en
P2093
Assmann KJ
Monnens LA
van Hinsbergh VW
van Setten PA
van de Kar NC
van den Heuvel LP
van der Velden TJ
P2888
P304
P356
10.1038/KI.1997.170
P407
P577
1997-04-01T00:00:00Z
P5875
P6179
1039308119